EA
AHCO icon

Emerald Advisers’s AdaptHealth AHCO Stock Holding History

Emerald Advisers’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,104,373
Closed -$13.7M – 212
2023
Q1 		$13.7M Sell
1,104,373
-22,758
-2% -$419K 0.66% 71
2022
Q4 		$21.7M Buy
1,127,131
+162,885
+17% +$3.44M 1.05% 37
2022
Q3 		$18.1M Buy
964,246
+941,018
+4,051% +$19.3M 0.93% 45
2022
Q2 		$419K Hold
23,228
– – 0.02% 184
2022
Q1 		$372K Sell
23,228
-519,530
-96% -$9.34M 0.01% 200
2021
Q4 		$13.3M Sell
542,758
-17,620
-3% -$414K 0.49% 80
2021
Q3 		$13.1M Sell
560,378
-125,155
-18% -$3.03M 0.47% 81
2021
Q2 		$18.8M Sell
685,533
-71,200
-9% -$2.03M 0.68% 63
2021
Q1 		$27.8M Buy
756,733
+753,155
+21,050% +$26.6M 1% 28
2020
Q4 		$134K Hold
3,578
– – ﹤0.01% 244
2020
Q3 		$78K Buy
+3,578
New +$75.1K ﹤0.01% 247

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Advisers's AHCO Position: Q2 2023 in Review

Emerald Advisers sold out of AdaptHealth (AHCO) in Q2 2023, closing a stake of 1,104,373 shares — an estimated $13.7M sold.

Emerald Advisers first reported a position in AHCO in Q3 2020 and held it in 11 quarters. The position peaked at $27.8M in Q1 2021. 182 funds tracked by Wall St. Rank hold AHCO as of Q2 2023.

  • Emerald Advisers reported no remaining AdaptHealth position as of Q2 2023 after selling out during the quarter.
  • Emerald Advisers sold 1,104,373 AdaptHealth shares in Q2 2023, an estimated $13.7M.
  • Emerald Advisers first reported a position in AdaptHealth in Q3 2020 and held it in 11 quarters.
  • Emerald Advisers's AdaptHealth position peaked at $27.8M in Q1 2021.
  • 182 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2023.

Based on Emerald Advisers's 13F filing for Q2 2023, filed 25 Jul 2023.